Log In
Print
BCIQ
Print
Print this Print this
 

MK-8931

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionBeta-site APP-cleaving enzyme 1 (BACE1) inhibitor
Molecular Target Beta-site APP-cleaving enzyme 1 (BACE1)
Mechanism of ActionBeta-site APP-cleaving enzyme 1 (BACE1) inhibitor
Latest Stage of DevelopmentPhase II/III
IndicationAlzheimer's disease (AD)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today